Skip to main content

Table 3 Main determinants of serum vaspin in the groups with metabolic syndrome (MetS +), newly-diagnosed type 2 diabetes (NDT2D), normal glucose tolerance (NGT), and in the NGT subgroups with (NGT + MetS) and without (NGT–MetS) MetS

From: Is vaspin related to cardio-metabolic status and autonomic function in early stages of glucose intolerance and in metabolic syndrome?

Stepwise multiple regression (t, p) F (df) p R R2
Predictor variable
Invaspin (MetS+)
 Model 1: age (3.20, p = 0.002) 10.22 (1.114) p = 0.002 0.074 0.082
 Model 2: age total body fat (3.10, p = 0.002)
(2.26, p = 0.026)
7.86 (2.113) p = 0.001 0.107 0.122
lnvaspin (NDT2D)
 Model 1: total body fat (2.45, p < 0.020) 6.01 (1.33) p = 0.020 0.403 0.162
lnvaspin (NGT)
 Model 1: ln(RFa deep breathing) (−3.16, p = 0.002) 10.0 (1.68) p = 0.002 0.358 0.128
lnvaspin (NGT – MetS)
 Model 1: ln(RFa deep breathing) (−2.99, p = 0.005) 8.92 (1.33) p = 0.005 0.461 0.213
lnvaspin (NGT + MetS)
 Model 1: ln(LFa at rest) (−2.31, p = 0.027) 5.36 (1.33) p = 0.027 0.374 0.140
  1. ln—natural logarithmic transformation for skewed data distribution
  2. Statistical significant values are presented in italics